Patent · US Active

3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases

US8465763B2 · kind B2 · utility

0Cited by

3References

25Claims

0Family size

Assignee

RICHTER GEDEON NYRT. · HU

Inventors

Georg Schramm · Stolberg, DE
Christa Kneip · Aachen, DE

Key dates

Filing date	Jun 12, 2009
Grant date	Jun 18, 2013
Priority date	—
Expiry date	Jul 21, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q19/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of 3β-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3β-ol-20-one) and/or 3α-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3α-ol-20-one) for producing a medicament for treating skin, preferably human skin by means of topical application, and to a pharmaceutical or cosmetic composition containing 3β-hydroxychlormadinone acetate and/or 3α-hydroxychlormadinone acetate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.